Nominations Committee

Membership and Attendance

The Nominations Committee comprises the following Directors and met on three occasions for the year ended 31 March 2016: 

 


Member

Number of meetings attended

 Percentage attendance

Anil Agarwal, Chairman

2/2 100%

Euan Macdonald

2/2 100%

Aman Mehta 

2/2 100%

Deepak Parekh 

2/2 100%

Katya Zotova

2/2 100%


Main Responsibilities 

The main responsibilities of the Nominations Committee are to:

  • Review the structure, size and composition of t he Board, including the skills, experience and diversity of its members and recommend changes to the composition that are deemed necessary;
  • Review the policy in respect of diversity on the Board and consider Board composition in light of the benefits of diversity, including gender;
  • Consider candidates for appointment as either Executive or Non-Executive Directors and plan for succession in particular to the positions of the Executive Chairman and Chief Executive Officer;
  • Prepare a description of the role and capabilities required for appointments to the Board;
  • Identify suitable candidates for appointments to the Board and its Committees and consider the use of external advisers to facilitate the search for candidates from a wide range of backgrounds; and
  • Recommend to the Board whether to reappoint a Non-Executive Director either at the end of their term of office or when put forward for re-election, having regard to their performance and ability to continue to contribute to the Board. The Nominations Committee will confer with Volcan Investments Limited in this respect under the terms of the Relationship Agreement.

The full terms of reference for teh Nominations Committee can be found here, and are also available on request from the Company Secretary.
 

Corporate Governance

Share Price

  • Last Close

    591.50
  • Mid Price

    583.00
  • Day's Change (p)

    -8.50
  • Day's Change (%)

    -1.44
  • 15 minute delayed share price from London Stock Exchange.

Subscribe to RNS alerts

Subscribe to email alerts regarding our regulatory news (RNS) releases

 
 
Close